Vytrus Biotech (XMAD:VYT) Change In Inventory: €-0.10 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:VYT Vytrus Biotech SA XMAD:VYT
67 GF Score
Price €17.60
GF Value €5.63
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech Change In Inventory?

Vytrus Biotech XMAD:VYT 67 Change In Inventory is €-0.10 Mil as of Dec. 2025. GuruFocus rates XMAD:VYT with a GF Score™ of 67/100 and a GF Value™ of €5.63 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Vytrus Biotech's change in inventory for the quarter that ended in Dec. 2025 was €-0.13 Mil. It means Vytrus Biotech's inventory increased by €0.13 Mil from Jun. 2025 to Dec. 2025 .

Vytrus Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was €-0.10 Mil. It means Vytrus Biotech's inventory increased by €0.10 Mil from Dec. 2024 to Dec. 2025 .

Vytrus Biotech's Total Inventories for the quarter that ended in Dec. 2025 was €0.62 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Vytrus Biotech's Inventory Turnover for the quarter that ended in Dec. 2025 was -0.44.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vytrus Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.14.

Vytrus Biotech  (XMAD:VYT) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vytrus Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.558/-0.244*365 / 2
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vytrus Biotech's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=-0.244 / 0.558
=-0.44

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vytrus Biotech's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.558 / 3.994
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Change In Inventory Related Terms

Vytrus Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Change In Inventory Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -0.04 -0.16 -0.14 0.03 -0.10

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.03 -0.01 0.03 -0.13
XMAD:VYT
67GF Score
Vytrus Biotech SA XMAD:VYT
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-0.10 Mil mean?
Vytrus Biotech (XMAD:VYT) has a Change In Inventory of €-0.10 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Vytrus Biotech and its competitors.
Is Vytrus Biotech's Change In Inventory too high?
Vytrus Biotech's current Change In Inventory is €-0.10 Mil. Overall, Vytrus Biotech has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's Change In Inventory compare to VRTX and REGN?
Vytrus Biotech's Change In Inventory of €-0.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Vytrus Biotech and its competitors. Vytrus Biotech's current Change In Inventory is €-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (XMAD:VYT) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.63, compared to a current price of €17.60 — trading 212.6% above its estimated fair value. The current Change In Inventory is €-0.10 Mil. Vytrus Biotech's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Vytrus Biotech (XMAD:VYT), the current Change In Inventory is €-0.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (XMAD:VYT) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €17.60 is trading 212.6% above its estimated GF Value™ of €5.63. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for XMAD:VYT:

  • Change In Inventory: €-0.10 Mil
  • GF Value™: €5.63 vs. price of €17.60 (212.6% above fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the XMAD:VYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges V5P:Germany
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
67GF Score

Get the complete analysis for XMAD:VYT

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.60
Price
€5.63
GF Value